.jpg)
.png)
NLA News
The United States Preventive Services Task Force (USPSTF) recently released its Final Recommendation Statement on Lipid Disorders in Children and Adolescents: Screening. NLA leadership disagrees with this release and communicated twice to USPSTF about the implications of this statement. The... more
During February—which is American Heart Month—the National Lipid Association (NLA) would like to recognize the important work underway by Million Hearts. This national initiative was launched by the Department of Health and Human Services in 2012, with the exciting goal of preventing 1 million... more
The 2016 American College of Cardiology (ACC) Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk By Carl Orringer, MD, FNLA Following “LDL Think Tank” meeting convened by ACC in October 2015, a meeting attended by... more
December 7, 2017 — The National Lipid Association (NLA) was recently awarded accredited provider status for Joint Accreditation in Inter-professional Continuing Education. Joint Accreditation offers organizations such as the NLA the opportunity to be simultaneously accredited to provide medical,... more
Sanofi and Regeneron announced on Monday, Feb. 11 alirocumab will be made available at a reduced list price to help lower patient out-of-pocket costs and improve access. This follows an earlier announcement in March 2018, when Sanofi and Regeneron committed to lower the U.S. net price for payers... more
An International Masters in Lipidology course debuted in Sydney, Australia in late October 2010. The international faculty included: Dr. Gerald Watts Dr. John Chapman, President of the European Atherosclerosis Society Dr. Richard O'Brien Dr. David Sullivan, Past President of the... more
The NLA is excited to share that we will host our first-ever virtual Scientific Sessions! Due to current travel restrictions and gathering limitations in the city of Chicago, the NLA has made the difficult decision to rescope our 2020 Scientific Sessions into a fully virtual conference held live on... more
Olezarsen met the primary endpoint with a statistically significant reduction in triglyceride levels versus placebo First study to show an absolute reduction in acute pancreatitis in FCS patients, with olezarsen 80 mg monthly dose reducing events by 100 percent... more
In 2014, the Foundation of the National Lipid Association (FNLA), Preventive Cardiovascular Nurses Association (PCNA), and Mended Hearts launched Cholesterol Counts, a program designed to accumulate Internet-based information on how much people know about their cholesterol, how much they care about... more
By Carl E. Orringer, MD, FACC; Pamela Bowe Morris, MD, FACC; Donald M. Lloyd-Jones, MD, FACC Guideline-directed patient care recommendations are based upon studies that make observations on groups of subjects who have specific characteristics and exhibit variable degrees of benefit or harm... more